North Bridge Venture Partners VI L P
Insider CIK 1327539 · LYRA 10% owner · MVNR 10% owner · BASE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYRA Lyra Therapeutics, Inc. | P Buy deriv | 2023-05-31 | 2023-06-02 | 601,806 | $0.13 | $78.2K | 601,806 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy deriv | 2023-05-31 | 2023-06-02 | 201,929 | $0.13 | $26.3K | 201,929 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy deriv | 2023-05-31 | 2023-06-02 | 98,973 | $0.13 | $12.9K | 98,973 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2023-05-31 | 2023-06-02 | 197,946 | $2.43 | $481.0K | 1,107,370 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2023-05-31 | 2023-06-02 | 1,203,612 | $2.43 | $2.92M | 2,521,745 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2023-05-31 | 2023-06-02 | 403,858 | $2.43 | $981.4K | 2,259,301 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-14 | 527,806 | $4.22 | $2.23M | 909,424 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-14 | 765,010 | $4.22 | $3.23M | 1,318,133 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-14 | 1,076,851 | $4.22 | $4.54M | 1,855,443 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 498,927 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 93,999 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 86,156 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 201,031 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 317,901 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 317,901 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 498,927 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 40,285 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 643,708 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 643,708 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 204,809 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 477,888 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 56,502 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion deriv | 2021-07-26 | 2021-07-26 | 131,840 | — | $0 | 0 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion | 2021-07-26 | 2021-07-26 | 2,402,147 | — | $0 | 2,594,381 | SEC↗ |
| BASE Couchbase, Inc. | P Buy | 2021-07-26 | 2021-07-26 | 40,625 | $24.00 | $975.0K | 1,987,084 | SEC↗ |
| BASE Couchbase, Inc. | P Buy | 2021-07-26 | 2021-07-26 | 94,791 | $24.00 | $2.27M | 2,689,172 | SEC↗ |
| BASE Couchbase, Inc. | C Conversion | 2021-07-26 | 2021-07-26 | 1,864,081 | — | $0 | 1,946,459 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,531,507 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 3,124,633 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise deriv | 2020-05-05 | 2020-05-06 | 13,449 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,995,489 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise deriv | 2020-05-05 | 2020-05-06 | 10,322 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 2,391,895 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,835,743 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 3,745,346 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 2,929,790 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 2,248,569 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 4,587,608 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 2,088,772 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,603,102 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 3,270,702 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,948,948 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,495,786 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 3,051,758 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,647,727 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 541,973 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,105,754 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,725,090 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 567,420 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,157,670 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise deriv | 2020-05-05 | 2020-05-06 | 21,060 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,545,953 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 1,186,496 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-06 | 2,420,729 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-06 | 651,453 | — | $0 | 651,453 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 5,568 | $16.00 | $89.1K | 324,057 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise | 2020-05-05 | 2020-05-06 | 13,449 | $8.63 | $116.1K | 485,378 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 7,255 | $16.00 | $116.1K | 478,123 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2020-05-05 | 2020-05-06 | 117,439 | $16.00 | $1.88M | 778,592 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2020-05-05 | 2020-05-06 | 57,561 | $16.00 | $921.0K | 381,618 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-06 | 319,303 | — | $0 | 319,303 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-06 | 471,929 | — | $0 | 471,929 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise | 2020-05-05 | 2020-05-06 | 21,060 | $8.63 | $181.7K | 672,513 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise | 2020-05-05 | 2020-05-06 | 10,322 | $8.63 | $89.1K | 329,625 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 11,360 | $16.00 | $181.8K | 661,153 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2020-05-05 | 2020-05-06 | 75,000 | $16.00 | $1.20M | 553,123 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | U Tender | 2015-04-29 | 2015-05-01 | 1,695,587 | $17.55 | $29.76M | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | U Tender | 2015-04-29 | 2015-05-01 | 831,072 | $17.55 | $14.59M | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | U Tender | 2015-04-29 | 2015-05-01 | 1,826,275 | $17.55 | $32.05M | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 810,970 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 3,736,119 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,831,222 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 5,567,338 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 2,375,330 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,164,243 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 3,539,575 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,975,540 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 968,291 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,261,642 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 2,512,281 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,231,369 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,604,421 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 1,269,855 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion deriv | 2013-11-13 | 2013-11-15 | 622,407 | — | $0 | 0 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion | 2013-11-13 | 2013-11-15 | 831,074 | — | $0 | 831,074 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion | 2013-11-13 | 2013-11-15 | 1,826,276 | — | $0 | 1,826,276 | SEC↗ |
| MVNR MAVENIR SYSTEMS INC | C Conversion | 2013-11-13 | 2013-11-15 | 1,695,587 | — | $0 | 1,695,587 | SEC↗ |